an OPEN Health Company

Time and Motion Case Studies


New oral chemotherapy agent providing an opportunity for oral plus IV regimen every 3 weeks vs standard of care IV regimen every 2 weeks. There was a need to demonstrate real life resource use and capacity released by oral chemo agent.


We conducted a prospective time and motion study in three tertiary care centres to look at the following:
• Staff time
• Chair time
• Use of consumables
• Patient  throughput
• Patient time


Data was used to generate a number of posters and abstracts and was available for economic modelling for HTA submissions and budget impact model for marketing purposes.

"Many thanks for doing such a good job in such difficult timelines. Your responsiveness, flexibility and pragmatism was great....the time and motion results form a pivotal part of the NICE response document"
Head of Health Economics, Roche Products


>> To Top    >> Back